MDL | - |
---|---|
Molecular Weight | 415.23 |
Molecular Formula | C19H12Cl2N4O3 |
SMILES | O=C1OC(C2=C(O)N(C3=NC4=CC=C(Cl)C(Cl)=C4N3)N=C2C)C5=C1C=CC=C5 |
RU.521 (RU320521) is a potent and selective cyclic GMP-AMP synthase (cGAS) inhibitor and inhibits cGAS-mediated interferon upregulation. RU.521 suppresses dsDNA-activated reporter activity with an IC 50 of 0.7 μM. RU.521 reduces constitutive expression of interferon in macrophages from a mouse model of Aicardi-Goutières syndrome (AGS) [1] .
IC50: 0.7 μM (dsDNA) [1]
RU.521 (5 mg/kg ; i.p. once) reduces symptoms from sepsis in mice [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Male 8-week-old male mice with LPS injection [2] |
Dosage: | 5 mg/kg |
Administration: | Intraperitoneal injection; 5 mg/kg once |
Result: | Increased cardiac function and reduced the inflammatory responses, oxidative stress and apoptosis in hearts of mice. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 83.33 mg/mL ( 200.68 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.4083 mL | 12.0415 mL | 24.0830 mL |
5 mM | 0.4817 mL | 2.4083 mL | 4.8166 mL |
10 mM | 0.2408 mL | 1.2042 mL | 2.4083 mL |
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.08 mg/mL (5.01 mM); Clear solution